SCHEMBL8428527

SCHEMBL8428527

CC(C)(C)OC(=O)n1ncc2cccnc21

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 1/20 0.44
FGFR4 P22455 1/20 0.44
POLB P06746 3/20 0.42
KDM4E B2RXH2 2/20 0.41
ELANE P08246 1/20 0.39
GPR119 Q8TDV5 3/20 0.39
MAPT P10636 1/20 0.37
PARP1 P09874 1/20 0.37
CKS1B P61024 1/20 0.37
SKP1 P63208 1/20 0.37
SKP2 Q13309 1/20 0.37
DTYMK P23919 1/20 0.37
EGFR P00533 1/20 0.37
ITK Q08881 1/20 0.37
GRM5 P41594 1/20 0.36
BCHE P06276 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29640851 1.00 FGFR1 (0.44) FGFR1FGFR4POLBKDM4EELANE
SCHEMBL14262719 0.79 FGFR1 (0.50) FGFR1FGFR4POLBKDM4EELANE
SCHEMBL15157126 0.78 KDM4E (0.44) FGFR1FGFR4POLBKDM4EPARP1
SCHEMBL30677230 0.78 ELANE (0.41) POLBKDM4EELANEGPR119MAPT
SCHEMBL2363023 0.78 ELANE (0.49) POLBKDM4EELANEEGFRITK
SCHEMBL29754118 0.78 ELANE (0.49) POLBKDM4EELANEEGFRITK
SCHEMBL21431482 0.77 CYP11B2 (0.44) POLBKDM4EELANECKS1BSKP1
SCHEMBL31690642 0.77 CYP11B2 (0.44) POLBKDM4EELANECKS1BSKP1
SCHEMBL30308887 0.77 POLB (0.42) POLBKDM4EELANEGPR119MAPT
SCHEMBL31037735 0.77 KDM4E (0.53) FGFR1FGFR4KDM4EELANEMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117616021-A (R) -glutarimide CRBN ligands and methods of use 百济神州有限公司 2024-02-27 CN disclosed
CN-112724134-B Azaindazole bipyridine derivative myeloid cell proliferation inhibitor, preparation method and application thereof in pharmacy 复旦大学 2022-04-01 CN disclosed
US-5859007-A TREATMENT OF DIABETES, OBESITY GLAXO WELLCOME INC. (US) 1999-01-12 US disclosed